Lianyungang, China

Yanqiu Wang

This inventor holds 2 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Jiangsu Kanion Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yanqiu Wang. Retrieved from https://idiyas.com/inventor/yanqiu-wang-0pbe91gg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yanqiu Wang - Innovator in Pharmaceutical Research

Introduction

Yanqiu Wang is a prominent inventor based in Lianyungang, China. She is currently associated with Jiangsu Kanion Pharmaceutical Co., Ltd. Despite having no granted patents to her name, her contributions to the field of pharmaceutical research are noteworthy.

Latest Patent Applications

Yanqiu Wang has been involved in several significant patent applications. One of her latest applications is titled "Recombinant Newcastle Disease Virus and Preparation Method Therefor, Recombinant Plasmid, and Use Thereof." This application describes a recombinant Newcastle disease virus that is engineered to replace an F protein of a Newcastle disease virus lasota with an F protein encoded by a specific DNA sequence. The recombinant virus is designed to be safe and effective in inhibiting tumor cells and promoting tumor cell apoptosis. Another application under the same title focuses on a recombinant Newcastle disease virus obtained by replacing the F protein with that of a virulent strain. This chimeric virus also demonstrates good safety and efficacy in treating tumors.

Conclusion

Yanqiu Wang's innovative work in the field of pharmaceutical research highlights her commitment to advancing medical science. Her latest patent applications reflect her dedication to developing effective treatments for serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…